AI and the Future of Urticaria
All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten ZuberbierShow Notes
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Hermenio Lima discuss the growing role of artificial intelligence (AI) in medicine and how it may influence urticaria care, research, and patient management in the future.
They discuss: 🔹 Can tools like ChatGPT help patients understand urticaria symptoms? 🔹 Why can AI support—but not replace—the physician? 🔹 How can AI assist doctors in accessing medical evidence more efficiently? 🔹 What role could machine learning play in urticaria registries and real-world data? 🔹 How may AI improve future research and patient stratification? 🔹 What are the risks and limitations of AI in clinical practice?
The episode explores both the opportunities and the challenges of integrating AI into allergy and urticaria care. From improving access to medical knowledge to analyzing large datasets, AI has the potential to support physicians and researchers—but clinical judgment and patient-centered care remain essential.
Key Learnings from the Episode: AI tools can provide useful information but cannot replace physicians. Patients should use AI cautiously and always seek medical advice. Physicians can use AI to access and summarize medical evidence more efficiently. Machine learning may improve analysis of real-world urticaria data. AI could help identify disease patterns and treatment responses. Clinical judgment remains essential in interpreting AI-generated information. Real-world registries like CURE may benefit from AI-supported analysis. Ethical and legal responsibilities remain with healthcare professionals. AI may improve future research and patient stratification in urticaria. Technology should support—not replace—patient-centered medical care.
Chapters: 00:00 Introduction to Urticaria and AI 03:28 The Role of AI in Patient Diagnosis 06:18 AI as a Tool for Physicians 09:20 AI in Urticaria Research and Data Collection 12:21 Future of AI in Allergy and Urticaria Treatment 15:01 Conclusion and Future Perspectives
Do you have suggestions for future episodes? Please provide feedback and offer your suggestions for future topics and expert selection here.
Feedback form: ATU: https://forms.office.com/e/m6a2uEdsUH
More from All Things Urticaria – Learning about urticaria with Prof. Dr. Torsten Zuberbier
In this episode of the UCARE Global Allergy and Asthma Excellence Network podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Angelo Valerio Marzano from Milan about urticarial vasculitis and its challenging differential diagnoses. They explore how clinicians can distinguish urticarial vasculitis from chronic urticaria and other dermatological or systemic conditions and discuss practical approaches to diagnosis and treatment.
In this episode of the Global Allergy and Asthma Excellence Network UCARE Podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Marta Ferrer from Spain about an important question: Is chronic spontaneous urticaria (CSU) only a skin disease, or is it a systemic inflammatory condition? Together, they discuss emerging evidence showing that urticaria affects far more than the skin and how this should influence patient management.
In this episode of the UCARE Global Allergy and Asthma Excellence Network (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier speaks with Prof. Akio Tanaka from Hiroshima University, Japan, about an important question many patients ask: how long will chronic urticaria last, and can treatment influence the course of the disease? They discuss disease modification, symptom control, and future research directions in urticaria management.
In this episode of the UCARE GA²LEN (Global Allergy and Asthma Excellence Network) podcast on Urticaria, Prof. Torsten Zuberbier and Prof. Maia Gotua discuss the role of infections in acute and chronic urticaria. They explore how infections can trigger, mimic, or worsen symptoms—and why careful clinical evaluation is key.
In this episode of “All Things Urticaria” — a podcast from UCARE, the Global Allergy and Asthma Excellence Network — Prof. Torsten Zuberbier and Prof. Ana Giménez-Arnau discuss the newly released international urticaria guidelines. Developed with contributions from more than 100 societies and hundreds of experts worldwide, these guidelines represent a major step forward in the management of chronic spontaneous urticaria (CSU).